(Nikkei) — Canon will invest up to $3.2 billion into purchasing companies in new business segments in robotics and life sciences. Canon is pushing forward with developing robotics for fully automating its camera production. By improving cost-competitiveness, it seeks to lift the ratio of domestic production from 40% percent to 60 percent in three years. “After polishing the production technology in the domestic market, we will sell it to others,” said CEO Fujio Mitarai, referring to such elements as the robots.
Plans for the life sciences call for introducing a genetic analyzer in the U.S. as early as the end of next year, as well as marketing related reagents and other consumables.Tags: Canon, Fujio Mitarai, genetic analyzer, life sciences, robotics